Every time I get a whiff of doubt, I check the valuation data for $(mrna)$ and my faith is reaffirmed instantly. Huge cash flow and cash reserve. Insanely low forward p/e of 8. Monster margins and ROE. This is CHEAP and will certainly go higher.